| Literature DB >> 23638430 |
Rui Hua1, Li-Min Liu, Yue-Dong Hu, Yun Zhou, Lei Chen.
Abstract
Valsalva retinopathy was described as a particular form of retinopathy, pre-retinal and subinternal limiting membrane haemorrhages in nature that rarely may break through and become subhyloid or intravitreal, secondary to a sudden increase in intrathoracic pressure. We reported a new way that Nd:YAG laser for ILM hyaloidotomy in order to drain the sub-ILM blood into vitreous cavity combined with intravitreal bevacizumab to improve the absorption of blood. Therapeutic alliance make significant outcome, protecting vision in time. We used spectralis OCT to observe sub-ILM mix cells and special ILM structure in this lesion for the first time, as the spectralis OCT can reach histology level imagination.Entities:
Keywords: bevacizumab; internal limiting membrane; spectralis OCT; valsalva retinopathy
Year: 2013 PMID: 23638430 PMCID: PMC3633768 DOI: 10.3980/j.issn.2222-3959.2013.02.25
Source DB: PubMed Journal: Int J Ophthalmol ISSN: 2222-3959 Impact factor: 1.779